Pfizer and AstraZeneca announce new investments of nearly $1 billion in France
Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly $1 billion, ahead of the start of this year's annual 'Choose France' busine...
Forget Johnson & Johnson: Buy This Better Healthcare Stock Instead
Johnson & Johnson is a stock that's full of risk these days. Its single-digit growth numbers don't look all that exciting, either.
AstraZeneca starts worldwide withdrawal of COVID vaccine
AstraZeneca has begun the worldwide withdrawal of its COVID vaccine - ending an era in which it saved millions of lives while being dogged by controversy.
AstraZeneca pulls its COVID-19 vaccine from the European market
LONDON — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator.
AstraZeneca to withdraw Covid vaccine worldwide, citing a drop in demand
Pharmaceutical giant AstraZeneca on Wednesday said it planned to withdraw its Covid-19 vaccine as demand for it has declined.
AstraZeneca withdraws COVID-19 vaccine
AstraZeneca said it's withdrawing its COVID-19 vaccine worldwide, with the company saying there's a surplus of available vaccines that are available.
AstraZeneca to withdraw its COVID-19 vaccine globally as demand dips, rare side effects revealed
The pharmaceutical giant AstraZeneca said on Tuesday it is withdrawing its COVID-19 vaccine worldwide due to low demand and following reports that the vaccine caused rare side effects.
AstraZeneca jumps on covid vaccine withdrawal
AstraZeneca PLC (LSE:AZN), the FTSE 100's largest constituent, surged 1.8% today after it said it would be withdrawing its COVID vaccine from global markets. AZ said the decision was because there...
AstraZeneca to withdraw Covid vaccine worldwide, The Telegraph reports
Anglo-Swedish drugmaker AstraZeneca is withdrawing its Covid vaccine worldwide, The Telegraph reported on Tuesday.
ANGLE teams up with AstraZeneca on a second assay
ANGLE PLC (AIM:AGL, OTCQX:ANPCY), a leader in liquid biopsy technology, has signed a supplier agreement with AstraZeneca PLC (LSE:AZN) to develop an androgen receptor (AR) detection assay to enhanc...
FTC Warns ‘Junk Patents' Could Make Drugs Like Ozempic Pricier—Here's How
The Federal Trade Commission is challenging hundreds of alleged “junk” patent listings filed by several pharmaceutical companies, which regulators claim could increase prices for medications like N...
'A shadow of what I was': Dad who suffered brain injury days after getting COVID jab sues AstraZeneca
A dad who suffered a brain injury just days after receiving a British-developed COVID vaccine has told Sky News he would never have had the jab if he had known of the risk of rare but serious side ...
AstraZeneca tells court Covid vaccine can cause rare side effect
AstraZeneca PLC (LSE:AZN) has admitted in court that its Covid-19 vaccines can cause rare side effects. A legal document submitted to London's High Court in February said the vaccine, developed alo...
AstraZeneca shares worth £135, says investment bank
Barclays has raised its price target for shares in AstraZeneca PLC (LSE:AZN) after Thursday's significantly better-than-expected first-quarter numbers. The investment banking arm of the high street...
AstraZeneca (AZN) Q1 Earnings & Sales Beat Estimates, Stock Up
AstraZeneca (AZN) beats first-quarter estimates for earnings and sales, driven by increased demand for its key oncology and rare disease drugs.
Related Companies